| P2093 | author name string | Martin Edwards | |
| | John M Moriarty | |
| | Adam N Plotnik | |
| P2860 | cites work | Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial | Q48087063 |
| | Treatment of intracerebral hemorrhage with tranexamic acid after thrombolysis with tissue plasminogen activator | Q48670485 |
| | Early and late clinical outcomes of pulmonary embolectomy for acute massive pulmonary embolism. | Q51531783 |
| | Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. | Q54195441 |
| | Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators | Q67273191 |
| | Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis | Q69952849 |
| | Medical compared with surgical treatment for massive pulmonary embolism | Q72668477 |
| | Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism | Q74604660 |
| | Mechanical Thrombectomy for Early Treatment of Massive Pulmonary Embolism | Q79174515 |
| | Management of unsuccessful thrombolysis in acute massive pulmonary embolism | Q83143074 |
| | Improved midterm outcomes for type A (central) pulmonary emboli treated surgically | Q83826757 |
| | Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism | Q84733867 |
| | Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24633053 |
| | Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial | Q28285511 |
| | Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) | Q28292426 |
| | Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data | Q33187906 |
| | Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) | Q33607475 |
| | Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association | Q34172244 |
| | 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism | Q34436061 |
| | Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report | Q34513594 |
| | Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques | Q35010375 |
| | Comparison of percutaneous ultrasound-accelerated thrombolysis versus catheter-directed thrombolysis in patients with acute massive pulmonary embolism. | Q35013319 |
| | Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). | Q35083166 |
| | The epidemiology of venous thromboembolism. | Q35157791 |
| | Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis | Q35189903 |
| | Open pulmonary embolectomy for treatment of major pulmonary embolism | Q35679139 |
| | Bradyarrhythmias during use of the AngioJet system | Q36631316 |
| | Catheter embolectomy for acute pulmonary embolism | Q36910258 |
| | Management of thrombolysis-associated symptomatic intracerebral hemorrhage | Q36950625 |
| | Intensive care unit management of patients with severe pulmonary hypertension and right heart failure | Q37893845 |
| | Pulmonary embolism as a cause of cardiac arrest: presentation and outcome | Q39537836 |
| | Early Experience with AngioVac Aspiration in the Pulmonary Arteries | Q40368831 |
| | A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study | Q41444320 |
| | Decision making in the surgical treatment of massive pulmonary embolism | Q42065458 |
| | Bradyarrhythmias during rheolytic pharmacomechanical thrombectomy for deep vein thrombosis | Q43015058 |
| | Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. | Q43802931 |
| | Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism | Q44175857 |
| | Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER). | Q44687254 |
| | Fibrinolysis for patients with intermediate-risk pulmonary embolism | Q45144900 |
| | Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). | Q45912871 |
| | Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy--should surgical indications be revisited? | Q45954828 |
| | Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism | Q47989601 |
| P433 | issue | 2 | |
| P921 | main subject | thrombectomy | Q2429588 |
| P304 | page(s) | 108-115 | |
| P577 | publication date | 2018-06-04 | |
| P1433 | published in | Seminars in interventional radiology | Q26842882 |
| P1476 | title | Intervention in Massive Pulmonary Embolus: Catheter Thrombectomy/Thromboaspiration versus Systemic Lysis versus Surgical Thrombectomy | |
| P478 | volume | 35 | |